GlassScriptPhysician profile
Minh-Tri Nguyen
NPI 1679940076
$7,720.32
in general payments reported to CMS, 2019-2025
16 companies · $2,793 in 2025
The $2,793 reported for 2025 was more than what 79% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $49.84 · 2021: $177 · 2022: $189 · 2023: $411 · 2024: $3,512 · 2025: $2,793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Travel and Lodging: $1,771 · Food and Beverage: $1,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Travel and Lodging | $1,771.42 |
| Food and Beverage | $1,443.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,396.83 | 2024-2025 | |
| Ethicon US, LLC | $692.69 | 2019-2025 | Vistaseal, Evarrest, Ethicon |
| Veloxis Pharmaceuticals, INC. | $267.34 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $202.01 | 2021-2025 | Nulojix |
| Mallinckrodt Hospital Products INC. | $185.03 | 2021-2025 | Terlivaz |
| Baxter Healthcare | $177.50 | 2019-2021 | |
| Stemline Therapeutics INC. | $172.05 | 2025 | Orserdu |
| Depuy Synthes Sales INC. | $133.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.19 | 2025 | |
| Histosonics, INC. | $92.94 | 2024 | |
| Integra Lifesciences Corporation | $61.85 | 2024-2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Olympus America INC. | $58.10 | 2022-2025 | Olympus |
| Janssen Biotech, INC. | $56.92 | 2024 | Rybrevant |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.96 | 2023-2024 | Xifaxan |
| Hemosonics LLC | $35.58 | 2023 | Quantra Qplus System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xvivo Perfusion INC. | $18.21 | 2024 | Xvivo Perfusion System (Xps) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minh-Tri Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.